Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2378
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion

Chen D, Li X, Zhao H, Fu Y, Yao F, Hu J, Du N

Year : 2014| Volume: 51| Issue : 7 | Page no: 82-85

   This article has been cited by
1 Management of Pleural Effusion Secondary to Malignant Mesothelioma
Valeria Musso, Cristina Diotti, Alessandro Palleschi, Davide Tosi, Alberto Aiolfi, Paolo Mendogni
Journal of Clinical Medicine. 2021; 10(18): 4247
[Pubmed]  [Google Scholar] [DOI]
2 Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion
Dawei Chen, Xinyu Song, Fang Shi, Hui Zhu, Haiyong Wang, Nasha Zhang, Yan Zhang, Li Kong, Jinming Yu
Oncotarget. 2017; 8(21): 35262
[Pubmed]  [Google Scholar] [DOI]
3 Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
Dawei Chen, Yan Zhang, Fang Shi, Hui Zhu, Minghuan Li, Kaijun Chen, Li Kong, Jinming Yu
Oncotarget. 2016; 7(32): 52436
[Pubmed]  [Google Scholar] [DOI]
4 Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases
D. Marquez-Medina,S. Popat
Clinical and Translational Oncology. 2016; 18(8): 760
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow